Top Markets
#1 MowCat MowCat +49.01%
#2 Velvet Velvet +26.59%
#3 Bermuda Shorts Bermuda Shorts +25.22%
#4 Biconomy Biconomy +21.45%
#5 Derive Derive +20.93%
#6 Audiera Audiera +19.36%
#7 Quack AI Quack AI +19.08%
#8 aPriori aPriori +18.64%
#9 Perle Perle +12.16%
#10 DODO DODO +11.93%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lakewood-Amedex Biotherapeutics Inc. Common Stock Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT
Clasificación en acciones #35448
This biopharmaceutical company is dedicated to developing innovative... This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Precio por acción
$2.23
Última sincronización: 2026-08-14
Capitalización bursátil
$3.90M
Cambio (1 día)
-4.48%
Cambio (1 año)
-
País
US
Comercio Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)

Categoría

Healthcare
Ratio P/S de Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Lakewood-Amedex Biotherapeutics Inc. Common Stock, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Lakewood-Amedex Biotherapeutics Inc. Common Stock desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE